MedPath

Phase IIb clinical trial on selected strains of probiotic lactobacilli packed as Capsules/Tablets for colonization potential and efficacy against recurrence of Bacterial Vaginosis

Phase 2
Conditions
Health Condition 1: null- Recurring episodes of Bacterial Vaginosis in women
Registration Number
CTRI/2010/091/000236
Lead Sponsor
Department of Biotechnology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

1.Women between age groups of 18-45 with regular cycles

2.Clinical history of chronic and/ or recurring episodes of abnormal vaginal dischargre. On pelvic examination,they are seen to have either excessive or unhealthy vaginal discharge.

3.Willing to participate in the study after having been explained about the nature of the body. Willing to return for follow up after 5-7 days of completion of treatment and thereafter on monthly basis for 3 months in part I of study.

Exclusion Criteria

1.Known case of diabetes mellitus.
2. Suspected/confirmed pregnancy.
3.Suspected or known malignancy of reproductive tract
4.Less than 6 weeks since last delivery or abortion
5.H/O severe allergic reaction
6. Abnormalities of vaginal anatomy which will interfere with placement of drug
7. Known systemic diseases, immuno-compromised states
8. Adnexal mass or tenderness
9. Received a course of antibiotic therapy, less than 14 days prior to enrollment
10. Dysfunction uterine bleeding
11.Vaginal polyp

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath